Rio Grande Neurosciences
732a Chenery Street
San Francisco
California
94131
United States
Tel: 505-438-6899
About Rio Grande Neurosciences
Rio Grande Neurosciences Inc. (RGN) is a Santa Fe, New Mexico-based neurotechnology company focused on developing, acquiring, and licensing non-invasive brain stimulation (NIBS) therapies used to treat pathologies of the central nervous system. There is an extreme paucity of therapies available for patients suffering from brain trauma, psychiatric illness, and chronic neurological diseases. Drug trials aimed at treating these conditions have repeatedly failed, underscoring the need for novel approaches to therapy and NIBS treatments have demonstrated encouraging results.YEAR FOUNDED:
2011
LEADERSHIP:
CEO: Steven Gluckstern
CSO (Chief Strategist): Sean Hagberg, PhD
CSO (Chief Science Officer): Blake Gurfein, PhD